Table 2.

Genomic arrangement of exons and the components of splicing variants

Exons	Genomic	Length	5 α 3 α	5 α 3 β	5 β 3 α	5 β 3 β
1	1–30	30	–	–	1–30	1–30
2	9610–9777	168	—	—	31–198	31–198
3	23 406–23 541	136	—	—	199–334	199–334
4	69 068–69 215	148	1–148	1–148	—	—
5	117 312–118 891	1580	149–1728	149–1728	335–1914	335–1914
6	140 392–140 599	208	1729–1936	1729–1936	1915–2122	1915–2122
7	144 737–144 810	74	1937–2010	1937–2010	2123–2196	2123–2196
8	145 179–145 384	206	2011–2216	2011–2216	2197–2402	2197–2402
9a.b	149 839–150 158	320	2217–2537	—	2403–2723	—
10	158 905–159 050	146	—	2217–2362	—	2403–2548
11	160 198–160 298	101	—	2363–2463	—	2549–2649
12	166 484–166 565	82	—	2464–2545	—	2650–2731
13	170 430–170 586	157	—	2516–2702	—	2732–2888
14	173 171–173 273	103	—	2703–2805	—	2889–2991
15	209 940–210 056	117	—	2806–2922	—	2992–3108
16	219 002–219 061	60	—	2923–2982	—	3109–3168
17	226 955–227 734	780	—	2983–3762	—	3169–3948

^aOne isolate (Accession # BC033618) from the embryonic carcinoma shows an alternative end (nt 152 406) of this exon

^bIn this study, sequence analysis of cDNAs indicates an additional “c” between nt 149918–149919 in the genomic sequence